Literature DB >> 30548385

Early development of the Australia and New Zealand Musculoskeletal Clinical Trials Network.

Rachelle Buchbinder1,2, Allison Bourne1,2, Jane Latimer3,4, Ian Harris4,5, Samuel L Whittle5,6, Bethan Richards4,7, William J Taylor8,9,10, Ornella Clavisi11, Sally Green12, Rana S Hinman13, Lyn March14, Richard Day15, Manuela L Ferreira16, Laurent Billot17, Chris G Maher3,4.   

Abstract

The Australia and New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network was formed to build capacity and infrastructure for high-quality musculoskeletal clinical trials in our region. The purpose of this paper is to describe the steps taken in its formation to help others interested in establishing similar networks. In particular, we describe the steps taken to form the collaboration and our progress in achieving our vision and mission. Our aim is to focus on trials of highest importance and quality to provide definitive answers to the most pressing questions in our field.
© 2018 Royal Australasian College of Physicians.

Entities:  

Keywords:  arthritis; capacity building; clinical trial; multi-centre; musculoskeletal disease

Year:  2020        PMID: 30548385     DOI: 10.1111/imj.14191

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  3 in total

1.  Activities supporting the growth of Clinical Trial Networks in Australia.

Authors:  Fiona Nemeh; Rachelle Buchbinder; Carmel M Hawley; Mark R Nelson; Jacqui G Waterkeyn; Christopher M Reid
Journal:  Trials       Date:  2022-01-28       Impact factor: 2.279

2.  Research activities in general medicine: a scoping survey by the Internal Medicine Society of Australia and New Zealand.

Authors:  Ar K Aung; Robert Pickles; Anne Knight; Leigh-Anne Shannon; Andrew Bowers; Sinead Donnelly; Douglas F Johnson; Ian A Scott; Elizabeth L Potter
Journal:  Intern Med J       Date:  2022-08-10       Impact factor: 2.611

3.  Capacity Building for a New Multicenter Network Within the ECHO IDeA States Pediatric Clinical Trials Network.

Authors:  Robert D Annett; Scott Bickel; John C Carlson; Kelly Cowan; Sara Cox; Mark J Fisher; J Dean Jarvis; Alberta S Kong; Jessica S Kosut; Kurtis R Kulbeth; Abbot Laptook; Pearl A McElfish; Mary M McNally; Lee M Pachter; Barbara A Pahud; Lee A Pyles; Jennifer Shaw; Kari Simonsen; Jessica Snowden; Christine B Turley; Andrew M Atz
Journal:  Front Pediatr       Date:  2021-07-14       Impact factor: 3.569

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.